口服脊髓灰质炎疫苗

  • 网络OPV;Oral polio vaccine;bOPV;Oral poliovirus vaccine,OPV
口服脊髓灰质炎疫苗口服脊髓灰质炎疫苗
  1. 本文研究了乙型肝炎疫苗与卡介苗、百白破联合制剂、口服脊髓灰质炎疫苗同时接种的免疫效果及相互间干扰情况。

    The immune effect and interaction of simultaneous inoculation of hepatitis B vaccine with BCG ; DTP and OPV were studied .

  2. 来自受脊髓灰质炎影响地区的旅行者,应在行前获得脊髓灰质炎疫苗完整程序的接种,出发前至少应获得一剂口服脊髓灰质炎疫苗。

    Travelers from polio-affected areas should have a full course of vaccination against polio before leaving , with a minimum one dose of OPV before departure .

  3. 上海市1980~1998年报告9例口服脊髓灰质炎疫苗相关病例(VAPP)。

    During 1980 ~ 1998 , there were 9 cases of vaccine-associated paralytic poliomyelitis ( VAPP ) found in Shanghai .

  4. 从重要意义上来看,VDPV带来的微小风险与口服脊髓灰质炎疫苗产生的巨大公共卫生相关益处相比黯然失色。

    The small risk of VDPVs pales in significance to the tremendous public health benefits associated with OPV .

  5. 答:疫苗衍生脊髓灰质炎病毒(VDPV)是一种罕见的脊髓灰质炎病毒株,由口服脊髓灰质炎疫苗(OPV)里的病毒株遗传变异而来。

    A : A vaccine-derived poliovirus ( VDPV ) is a rare strain of poliovirus , genetically mutated from the strain contained in oral polio vaccine ( OPV ) .

  6. 采用快速调查方法对重点人群流动规律及口服脊髓灰质炎疫苗(OPV)强化免疫接种状况进行调查,从中发现江苏省流动人群以省内流动为主,其来源有地区性差别;

    Using rapid survey method to trace floating children and investigate polio supplementary immunization status , we found that floating population mainly came from inside of the province , and the districts they came from were different .

  7. 结果平果县1995~2003年四种疫苗[卡介苗(BCG)、口服脊髓灰质炎疫苗(OPV)、百白破联合疫苗(DPT)、麻疹疫苗(MV)]常规免疫估算接种率为55.44%~84.51%;

    Results The range of estimated vaccination rate for four bacterins was from 55.44 % to 84.51 % between 1995 and 2003 , including bacillus Calmette-Guerin ( BCG ), oral poliomyelitis vaccine ( OPV ), diphtheria pertussis tetanus associated vaccine ( DPT )? measles vaccine ( MV ) .

  8. 受到输入性脊髓灰质炎病毒影响的国家应按照世界卫生大会WHA59.1号决议,利用有关口服脊髓灰质炎疫苗开展大规模疫情应对活动,继续实施补充性常规免疫。

    Countries affected by poliovirus importations should continue to supplement routine immunization with large-scale outbreak response activities with the relevant OPV , as per the WHA Resolution WHA59.1 .

  9. 上海市1980~1998年口服脊髓灰质炎疫苗相关病例的流行病学分析

    Epidemiological Analysis of the Vaccine associated Paralytic Poliomyelitis in 1980-1998 in Shanghai

  10. 口服脊髓灰质炎疫苗效力标准品国际协作研究

    International Collaborative Study on Potency Standard for Oral Poliomyelitis Vaccine

  11. 口服脊髓灰质炎疫苗与相关病例发生危险性的流行病学分析

    Epidemic analysis of danger between oral polio vaccine and vaccine associated paralytic poliomyelitis

  12. 江西省2000年口服脊髓灰质炎疫苗扫荡式免疫活动实施状况分析

    Analysis on Implementation of the Mop-up Immunization of Oral Polio Vaccine in 2000 in Jiangxi Province

  13. 婴儿接种首剂三价口服脊髓灰质炎疫苗后疫苗病毒排毒状况观察

    Observation on Polio Vaccine Virus Excretion in Immunized Infants Given First Dose Trivalent Oral Polio Vaccine

  14. 云南省本地儿童与流动儿童口服脊髓灰质炎疫苗免疫状况分析

    Analysis of the Oral Poliomyelitis Vaccine Immunization Status of Mobile Resident Children and Permanent Resident Children in Yunnan Province

  15. 口服脊髓灰质炎疫苗包含一种脊髓灰质炎减毒活病毒,能引发体内的免疫反应。

    The oral polio vaccine contains a weakened version of poliovirus , activating an immune response in the body .

  16. 于竞进等人的研究表明,这些儿童被一种病毒感染,它的遗传结构与用于口服脊髓灰质炎疫苗中的减活病毒类似。制作减活疫苗的病毒其活性已经被减弱,不能引发疾病。

    Yu 's study showed that children had been infected by a virus genetically-similar to the one used in the oral vaccine .

  17. 在20世纪50年代冷战期间,苏联和美国的科学家合作开发了一种口服脊髓灰质炎疫苗。

    During the late1950s , despite the Cold War , Soviet and US scientists worked together to develop an oral polio vaccine .

  18. 过去曾获得三剂或更多剂量的口服脊髓灰质炎疫苗接种的旅行者,应在行前再获一次脊髓灰质炎疫苗接种。

    Travelers who have in the past received three or more doses of OPV should be offered another dose of polio vaccine before departure .

  19. 为应对此次疫情,塔吉克斯坦已利用口服脊髓灰质炎疫苗开展了四轮国家免疫日活动。

    In response to the outbreak , four rounds of national immunization days ( NIDs ) with oral polio vaccine have been held in Tajikistan .

  20. 云南省2002年与四川省毗邻地区急性弛缓性麻痹病例主动搜索及口服脊髓灰质炎疫苗强化免疫结果分析

    An Active Search for AFP Cases in the Contiguous Region of Yunnan and Sichuan Provinces in 2002 and Analysis on Supplementary lmmunization of Oral Polio Vaccine

  21. 是否有必要进行更多轮次的口服脊髓灰质炎疫苗大规模免疫接种活动,将以正在进行的流行病学和实验室数据评估情况作为根据。

    The need for additional rounds of mass oral polio vaccine ( OPV ) immunization will be based on an ongoing evaluation of epidemiological and laboratory data .

  22. 例如,在尼日利亚,宗教和政治领导人赞同一些谣言,即口服脊髓灰质炎疫苗是美国人的传播艾滋病病毒并导致不育的一个阴谋。

    In Nigeria , for example ," religious and political leaders endorsed rumours that oral polio vaccine was an American conspiracy to spread HIV and cause infertility " .

  23. 一些活疫苗,比如口服脊髓灰质炎疫苗;黄热病疫苗;麻疹,腮腺炎和风疹疫苗并不含硫柳汞,因为后者会杀死免疫成分。

    Live vaccines , such as oral poliovirus vaccine ; yellow fever vaccine ; and measles , mumps and rubella vaccines , do not contain thiomersal , because it would kill the immunizing component .

  24. 除最近这笔2500万美元赠款外,该基金会以前提供了8500万美元的资助,包括1000万美元用于研制单价口服脊髓灰质炎疫苗。

    In addition to this most recent US $ 25 million grant , the Foundation previously provided US $ 85 million in funding , including US $ 10 million for the development of the monovalent oral polio vaccine .

  25. 结果2000-2004年卡介苗、口服脊髓灰质炎疫苗、百白破混合制剂、麻疹疫苗、乙型肝炎疫苗的常规免疫报告接种率为98.71%~99.65%,估算接种率为72.86%~112.11%,与报告接种率之间还有差距。

    Results The immunization coverage rates of five vaccines ( BCG , OPV , DPT , MV , HBV ) ranged from 98.71 % to 99.65 % , while the estimated rates ranged from 72.86 % to 112.11 % in 2000-2004 , indicating significance with the reported rates .

  26. [目的]为探讨口服脊髓灰质炎活疫苗(OPV)与脊髓灰质炎疫苗相关病例(VAPP)的关系。

    [ Objective ] To discuss the association of oral polio vaccine ( OPV ) and vaccine associated paralytic poliomyelitis ( VAPP ) .

  27. 对1994~1998年共5年间生产的口服脊髓灰质炎活疫苗糖丸的病毒滴度的检定结果进行质量分析。

    We summarized the control results of Oral Live Polimyelitis Vaccine Drage ′ e virus titer in our Institute from 1994 to 1998 , and also analyzed the results .

  28. 目的探索影响口服脊髓灰质炎减毒活疫苗(OPV)感染性滴度检测的主要因素。

    Objective To assess the factors in the detection of infectious titers of oral poliovirus vaccine .

  29. 目的:考察口服脊髓灰质炎减毒活疫苗糖丸(OPV)在-20℃温度下保存的稳定性。

    Objective : To detect the stabilities of live attenuated oral poliomyelitis vaccine balls stored under-20 ℃ .

  30. 目的分析口服脊髓灰质炎减毒活疫苗(OPV)猴体神经毒力试验病理学改变特征,对OPV猴体神经毒力试验两种注射方法进行评价。

    Objective To analyze the pathological lesion of monkeys caused by neurovirulence test of oral poliovirus vaccine ( OPV ) and evaluate the two injection methods for the test .